438 related articles for article (PubMed ID: 16580667)
61. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
62. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
[TBL] [Abstract][Full Text] [Related]
63. The androgen receptor and prostate cancer invasion.
Bonaccorsi L; Muratori M; Marchiani S; Forti G; Baldi E
Mol Cell Endocrinol; 2006 Feb; 246(1-2):157-62. PubMed ID: 16376012
[TBL] [Abstract][Full Text] [Related]
64. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP.
Koochekpour S; Lee TJ; Wang R; Sun Y; Delorme N; Hiraiwa M; Grabowski GA; Culig Z; Minokadeh A
J Cell Biochem; 2007 Jun; 101(3):631-41. PubMed ID: 17171640
[TBL] [Abstract][Full Text] [Related]
65. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
Zhang H; Lü JJ; Gao QZ; Zhang J
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
[TBL] [Abstract][Full Text] [Related]
66. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
67. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
68. Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.
Hammacher A; Thompson EW; Williams ED
Int J Biochem Cell Biol; 2005 Feb; 37(2):442-50. PubMed ID: 15474988
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines.
Cronauer MV; Schulz WA; Burchardt T; Ackermann R; Burchardt M
Oncogene; 2004 Apr; 23(20):3541-9. PubMed ID: 15077179
[TBL] [Abstract][Full Text] [Related]
70. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.
Nakamura K; Yasunaga Y; Segawa T; Ko D; Moul JW; Srivastava S; Rhim JS
Int J Oncol; 2002 Oct; 21(4):825-30. PubMed ID: 12239622
[TBL] [Abstract][Full Text] [Related]
71. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells.
Zegarra-Moro OL; Schmidt LJ; Huang H; Tindall DJ
Cancer Res; 2002 Feb; 62(4):1008-13. PubMed ID: 11861374
[TBL] [Abstract][Full Text] [Related]
72. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells.
Basrawala Z; Alimirah F; Xin H; Mohideen N; Campbell SC; Flanigan RC; Choubey D
Oncogene; 2006 May; 25(19):2812-7. PubMed ID: 16331249
[TBL] [Abstract][Full Text] [Related]
73. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus.
Tihan T; Harmon JW; Wan X; Younes Z; Nass P; Duncan KL; Duncan MD
Anticancer Res; 2001; 21(4B):3107-14. PubMed ID: 11712819
[TBL] [Abstract][Full Text] [Related]
74. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
[TBL] [Abstract][Full Text] [Related]
75. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
Ravindranath MH; Muthugounder S; Presser N; Selvan SR; Portoukalian J; Brosman S; Morton DL
Biochem Biophys Res Commun; 2004 Nov; 324(1):154-65. PubMed ID: 15464996
[TBL] [Abstract][Full Text] [Related]
76. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines.
Hollas W; Hoosein N; Chung LW; Mazar A; Henkin J; Kariko K; Barnathan ES; Boyd D
Thromb Haemost; 1992 Dec; 68(6):662-6. PubMed ID: 1337629
[TBL] [Abstract][Full Text] [Related]
77. The androgen receptor mRNA.
Yeap BB; Wilce JA; Leedman PJ
Bioessays; 2004 Jun; 26(6):672-82. PubMed ID: 15170865
[TBL] [Abstract][Full Text] [Related]
78. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
[TBL] [Abstract][Full Text] [Related]
79. Distant metastases from prostatic carcinoma express androgen receptor protein.
Hobisch A; Culig Z; Radmayr C; Bartsch G; Klocker H; Hittmair A
Cancer Res; 1995 Jul; 55(14):3068-72. PubMed ID: 7541709
[TBL] [Abstract][Full Text] [Related]
80. Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis.
Skjøth IH; Issinger OG
Int J Oncol; 2006 Jan; 28(1):217-29. PubMed ID: 16327999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
